Drug Safety and Pharmacovigilance

Drug safety relates to the potential for adverse effects related to the administration of drugs. Efforts to establish the safely profile of drugs begin early in their development, with in vitro and in vivo toxicity testing, and continue through clinical trials leading up to drug approval and following approval in specific post-marketing studies or general pharmacovigilance efforts. Pharmacovigilance (PV or PhV), also known as drug safety, is the pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products.The etymological roots for the word "pharmacovigilance" are: pharmakon (Greek for drug) and vigilare (Latin for to keep watch). As such, pharmacovigilance heavily focuses on adverse drug reactions, or ADRs, which are defined as any response to a drug which is noxious and unintended, including lack of efficacy (the condition that this definition only applies with the doses normally used for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological disorder function was excluded with the latest amendment of the applicable legislation). Medication errors such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are also of interest, even without an adverse event, because they may result in an adverse drug reaction Signal Detection in Drug Safety

 

     

     

      Related Conference of Drug Safety and Pharmacovigilance

      April 04-05, 2024

      17th European Biosimilars Congress

      Madrid, Spain
      April 11-12, 2024

      5th Annual Congress on Antibiotics and Bacterial Infections

      Amsterdam, Netherlands
      May 09-10, 2024

      4th Global Summit on Pharmaceutical Research

      Barcelona, Spain
      May 16-17, 2024

      18th World Drug Delivery Summit

      Rome, Italy
      May 30-31, 2024

      9th Pharmaceutical Chemistry Conference

      Paris, France
      July 25-26, 2024

      34th Annual European Pharma Congress

      Frankfurt, Germany
      September 11-12, 2024

      9th International Conference on Future Pharma and Innovations

      Amsterdam, Netherlands
      September 25-26, 2024

      4th World Congress on Rare Diseases & Orphan Drugs

      Paris, France
      November 26-27, 2024

      3rd World Conference on Pharma Industry and Medical Devices

      Zurich, Switzerland
      November 26-27, 2024

      3rd World Congress on Precision and Personalized Medicine

      Zurich, Switzerland
      November 28-29, 2024

      39th World Congress on Pharmacology and Therapeutics

      Paris, France
      November 28-29, 2024

      12th International Conference on Clinical Trials

      Vancouver, Canada
      December 05-06, 2024

      17th World Drug Delivery Summit

      Dubai, UAE

      Drug Safety and Pharmacovigilance Conference Speakers

        Recommended Sessions

        Related Journals

        Are you interested in